Vir Biotechnology, Inc.
Ticker: VIR
| Insider | Title |
|---|---|
| Ann M. Hanly | EVP Chief Technology Officer |
| Backer Marianne De | Chief Executive Officer, Director |
| Brent Sabatini | SVP, Chief Accounting Officer |
| Charles Elliott Sigal | Director |
| Clinton Bybee | 10% or greater ownership |
| Endurance (cayman) Ltd Svf | 10% or greater ownership |
| George A Scangos | Director |
| Herbert Virgin | EVP, Research CSO |
| Howard Horn | CFO |
| Investment Advisers (uk) Ltd Sb | 10% or greater ownership |
| Janet Napolitano | Director |
| Jason O'byrne | EVP Chief Financial Officer |
| Jeffrey S. Hatfield | Director |
| Johanna Friedl-naderer | EVP Chief Operating Officer |
| Keith Crandell | 10% or greater ownership |
| Mark Eisner | EVP and Chief Medical Officer |
| Norbert W Bischofberger | Director |
| Phillip A Sharp | Director |
| Phillip Pang | EVP Chief Medical Officer |
| Ramy Farid | Director |
| Robert J More | Director |
| Robert J Perez | Director |
| Robert Nelsen | Director |
| Saira Ramasastry | Director |
| Steven J. Rice | Chief Administrative Officer |
| Sung Lee | EVP Chief Financial Officer |
| Venture Fund Ix Overage, L.p. Arch | 10% or greater ownership |
| Venture Fund Ix, L.p. Arch | 10% or greater ownership |
| Venture Partners Ix Overage, L.p. Arch | 10% or greater ownership |
| Venture Partners Ix, L.p. Arch | 10% or greater ownership |
| Venture Partners Ix, Llc Arch | 10% or greater ownership |
| Verneuil Vanina De | EVP and General Counsel |
| Vicki L Sato | Director |
| Vision Fund (aiv M1) L.p. Softbank | 10% or greater ownership |